mci 154 has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamaguchi, K; Yamakawa, H; Yokoyama, M | 1 |
| Chen, HS; Hu, DY; Liu, LM; Lu, RQ; Ming, MJ; Nan, X | 1 |
2 other study(ies) available for mci 154 and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Humans; Imidazoles; Myocardial Infarction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Dysfunction, Left | 1997 |
Effects of MCI-154, a calcium sensitizer, on cardiac dysfunction in endotoxic shock in rabbits.
Topics: Animals; Calcium; Drug Evaluation, Preclinical; Female; Heart Diseases; Heart Function Tests; Hemodynamics; Lipopolysaccharides; Male; Myocardial Contraction; Pilot Projects; Pyridazines; Rabbits; Shock, Septic; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |